Liin Terallo
Freedom for New Cov!
Dr. Ghast Hark
,I hope that you'll forgive the unsolicited message. Your work has come to my attention on several occasions, particularly your research concerning biological responses to pharmacological agents. I suspect that makes you one of the few people who might find the following problem as interesting as I do.
I'm currently exploring the possibility of developing an agent whose effects are dependent upon specific biological markers. In simpler terms, I am interested in whether it would be possible to create a compound that induces a reliable, temporary state of unconsciousness in a general population while being substantially resisted (or rendered ineffective) by individuals possessing a predetermined genetic sequence, biomarker, or related physiological characteristic.
The distinction is important. I am not looking for a conventional sedative with varying levels of tolerance. The objective would be a deliberately selective biological response: two otherwise comparable individuals could be exposed to the same agent, yet only one would experience the intended effect because of a defined characteristic present within their biology.
Naturally, I have several hypotheses regarding how such selectivity might be achieved, but I would prefer not to anchor the research prematurely to my own assumptions. Your expertise may suggest mechanisms that I have overlooked.
If this concept interests you, I would be happy to provide the preliminary research and discuss the parameters I have been considering. I believe there may be a fascinating piece of molecular biology hidden within the problem, regardless of whether the eventual application proves practical.
And if nothing else, I suspect you might enjoy determining precisely why the problem is more difficult than it initially appears.
Respectfully,
Liin Terallo
Molecular Bioscientist